86 results
Page 2 of 5
8-K
EX-1.1
xweko5rj
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
c60rs29hi8cudwe7i ge
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
0aqh8
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-99.1
3huudjqvqne8ps4
10 Nov 21
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:16pm
8-K
EX-1.1
uexqztr0s69zo4
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-99.1
s0l4 l8dijybx89
5 May 21
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:01pm
8-K
09qrdh6
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-1.1
ry8evr0y
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
6upee 00v71y47cm5vd3
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
3t6ad0qys yp
23 Jun 20
Prospectus supplement for primary offering
4:06pm